GSK Investigational Site

Cheltenham, Victoria 3192

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed